Phc, Curcumin Relieve Prostate Cancer Patients

The first, published in the Journal of Cancer Science and Therapy, found curcumin supplementation (as BCM-95 Curcumin from DolCas Biotech ) significantly reduced therapy-related urinary symptoms in those undergoing radiation therapy (J Cancer Sci Ther. 2013, 5.10). In the study, 40 prostate cancer patients in external beam radiotherapy (EBRT) took either 3 g/d curcumin or placebo. Researchers measured seven urinary factors including urinary urgency, daytime urinary frequency and incontinence. The curcumin supplemented group experienced significant decreases in overall symptoms, including a 50-percent reduction in daytime urinary incidence and 40-percent decrease in incidence of daily activity limitations, compared to placebo. The study authors also noted, "It seems that at least in short term, curcumin does not have any unfavorable effect on treatment outcomes." Interim results from the Norris Comprehensive Cancer Center at the University of Southern California found a patented combination of green tea extract, saw palmetto fruit extract, lycopene, vitamin D and vitamin E (as Prostate Health Cocktail from OncoNatural) stabilized prostate specific antigen (PSA) in men with recurrent prostate cancer. Forty men competed the phase-two clinical trial; 23 percent of subjects had undergone primary radiation, 25 percent had undergone prostatectomy and 52 percent had both. PSA levels stabilized in 83 percent of participants after 12 weeks of supplementation, and 37.5 percent experienced declines. Final results of the study are awaiting publication. For more information, visit http://www.naturalproductsinsider.com/news/2014/01/phc-curcumin-relieve-prostate-cancer-patients.aspx.







arthritis early signs Tumeric & Curcumin Supplements Fail Quality Tests





Recent research has focused on curcuminoids, the specific compounds in turmeric including curcumin which give turmeric its orange-yellow color. Studies suggest a role for curcuminoids in the treatment of a range of diseases including ulcerative colitis, rheumatoid arthritis, and chronic anterior uveitis (an autoimmune disease of the eye), as well as for indigestion. anti-inflammatory property According to Nutrition Business Journal, sales of turmeric and curcumin supplements grew to $59 million in 2009, up from $43 million in 2008. Consumers need to select turmeric or curcumin supplements carefully to be sure they are getting a quality product. The products that failed our testing would deliver only a small fraction of the doses expected from their labels. In addition, because curcumin is poorly absorbed, certain specially formulated products may offer greater bioavailability, said Tod Cooperman, M.D., President of ConsumerLab.com. To help consumers get the best value from a supplement, ConsumerLab.com calculated the cost to obtain a 500 mg dose of curcuminoids, which ranged from 13 cents to 52 cents among products that passed testing, some of which included bioavailability enhancers. For the two products that failed testing, the costs were $3.44 and $7.88, due to the small amounts of curcuminoids that they actually contained. The ConsumerLab.com report is available at http://www.consumerlab.com/reviews/turmeric-curcumin-supplements-review/turmeric/ . For more information, visit http://www.opposingviews.com/i/tumeric-curcumin-supplements-fail-quality-tests.